FGP
CC icon

Freestone Grove Partners’s Chemours CC Stock Holding History

Freestone Grove Partners’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,155
Closed -$379K – 1007
2025
Q4 		$379K Buy
+32,155
New +$413K ﹤0.01% 623
2025
Q3 		– Sell
-83,850
Closed -$960K – 725
2025
Q2 		$960K Buy
+83,850
New +$945K 0.01% 441

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.2B AUM 137.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Freestone Grove Partners's CC Position: Q1 2026 in Review

Freestone Grove Partners sold out of Chemours (CC) in Q1 2026, closing a stake of 32,155 shares — an estimated $379K sold.

Freestone Grove Partners first reported a position in CC in Q2 2025 and held it in 2 quarters. The position peaked at $960K in Q2 2025. 450 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Freestone Grove Partners reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 32,155 Chemours shares in Q1 2026, an estimated $379K.
  • Freestone Grove Partners first reported a position in Chemours in Q2 2025 and held it in 2 quarters.
  • Freestone Grove Partners's Chemours position peaked at $960K in Q2 2025.
  • 450 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.